Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Schulze-Koops et al

Ann Rheum Dis. 2023 Jan;82(1):e2. doi: 10.1136/annrheumdis-2020-219230. Epub 2020 Oct 30.

Affiliations

¹ IdISSC and Rheumatology, Hospital Clinico Universitario San Carlos, Madrid, Spain.
² IdISSC and Rheumatology, Hospital Clinico Universitario San Carlos, Madrid, Spain lleon.hcsc@salud.madrid.org.
³ Health Sciences, Universidad Camilo Jose Cela, Villafranca del Castillo, Spain.
⁴ Rheumatology, Hospital Clinico Universitario San Carlos, Madrid, Spain.
⁵ Rheumatology, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Spain.

PMID: 33127661
DOI: 10.1136/annrheumdis-2020-219230

No abstract available

Keywords: autoimmune diseases; epidemiology; health care; outcome assessment.

Publication types

Comment

MeSH terms

Arthritis, Rheumatoid* / complications
Arthritis, Rheumatoid* / drug therapy
Autoimmune Diseases* / epidemiology
COVID-19*
Hospitals
Humans
Rheumatic Diseases* / complications
Risk Factors